Endometrial responses to three different progestins in artificial cycles: a prospective, crossover study.
We found that there was no significant difference in endometrial responses to vaginal or IM P. But the response was suboptimal in cycles treated with dydrogesterone, suggesting that dydrogesterone treatment is not the preferred progestin for use in artificial cycles.
Li
T C
TC
Department of Obstetrics and Gynaecology, University of Sheffield, Jessop Hospital for Women, United Kingdom.
Aplin
J D
JD
Warren
A
A
Graham
R A
RA
Dockery
P
P
Cooke
I D
ID
D000282:Administration, Intravaginal; D000284:Administration, Oral; D000328:Adult; D004394:Dydrogesterone / Q000008:administration & dosage / Q000627:therapeutic use; D004717:Endometrium / Q000187:drug effects*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D007273:Injections, Intramuscular; D008597:Menstrual Cycle; D016649:Primary Ovarian Insufficiency / Q000188:drug therapy*; D011372:Progestins / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D011446:Prospective Studies
D011372:Progestins; D004394:Dydrogesterone